Investors can start the new year off right by digging into these three small but fiery stocks.
News & Analysis: Catalyst Pharmaceuticals
CPRX earnings call for the period ending September 30, 2020.
These companies are certainly risky, but they might have what it takes to deliver serious growth for investors.
Catalyst can't seem to catch a break in the clinic these days.
Pharmaceutical stocks are popular with Robinhood Investors, including three I would stay away from and one that I wouldn't.
These have the highest analyst ratings among Robinhood's 100 most popular stocks.
CPRX earnings call for the period ending June 30, 2020.
Firdapse fails to hit the mark in the clinic yet again.
Two biotechs have big risks, one is a buy, and the other is a big opportunity to consider.
Each of these three stocks are on Robinhood’s top 100 most-held list.